VERICI DX PLC
Develops AI-powered diagnostic tests for the kidney transplant market.
VRCI | IL
Overview
Corporate Details
- ISIN(s):
- GB00BM8HZD43
- LEI:
- 213800FI5WE4FVQ3G645
- Country:
- United Kingdom
- Address:
- AVON HOUSE, CF64 2EZ CARDIFF
- Website:
- https://www.vericidx.com/
- Sector:
- Real estate activities
Description
Verici Dx is an immuno-diagnostics company developing and commercializing a suite of proprietary tests for the kidney transplant market. The company's platform utilizes artificial intelligence-assisted transcriptomic analysis of RNA signatures to provide data-driven insights to clinicians. These tests are designed to decipher the body's immune response and other biological signals, enabling personalized risk assessment for organ injury, rejection, and graft failure. The goal is to assist clinicians in medical management throughout the transplant process, from pre-transplant to late-stage care, ultimately aiming to improve patient outcomes and long-term graft survival.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2022-01-12 15:00 |
Progress and strategy update
|
English | HTML • 28.8 KB | ||
| 2022-01-06 08:00 |
Clarava™ and Tuteva™ complete testing requirements
|
English | HTML • 16.8 KB | ||
| 2022-01-05 08:00 |
Collaboration with Illumina
|
English | HTML • 15.3 KB | ||
| 2022-01-04 08:00 |
Grant of two CPT Codes by AMA
|
English | HTML • 13.8 KB | ||
| 2021-12-17 14:19 |
Holding(s) in Company
|
English | HTML • 22.0 KB | ||
| 2021-11-08 08:00 |
Launch of Barbara T. Murphy Endowed Lectureship
|
English | HTML • 19.7 KB | ||
| 2021-11-01 08:00 |
Launch of Career Development Research Grant
|
English | HTML • 20.5 KB | ||
| 2021-09-13 08:01 |
Lorenzo Gallon, MD, Appointed as Chair of S.A.B
|
English | HTML • 17.8 KB | ||
| 2021-09-13 08:00 |
Half-year Report
|
English | HTML • 290.8 KB | ||
| 2021-09-06 08:00 |
Notice of Results
|
English | HTML • 12.6 KB | ||
| 2021-08-31 08:00 |
Patient enrolment completed
|
English | HTML • 15.3 KB | ||
| 2021-08-19 08:00 |
Appointment of Non-executive Director
|
English | HTML • 15.7 KB | ||
| 2021-07-27 08:00 |
Acceptance to CLIA Program
|
English | HTML • 14.6 KB | ||
| 2021-07-20 08:00 |
First European Clinical Trial Site Initiated
|
English | HTML • 16.0 KB | ||
| 2021-07-01 17:56 |
Directorate Change
|
English | HTML • 16.6 KB |
Automate Your Workflow. Get a real-time feed of all VERICI DX PLC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for VERICI DX PLC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for VERICI DX PLC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
